Market Overview

Morning Market Losers

Related CYTK
Why Does The Street Like Small-Caps Cytokinetics And Anavex?
Cytokinetics Presents Exploratory Analyses of Data from Phase 3 Clinical Trial of Dexpramipexole in Patients with ALS
Related ARQL
12 Biotechs With Binary Events Coming This Year
Benzinga's Top Upgrades

Cytokinetics (NASDAQ: CYTK) dropped 21.59% to $8.21 on failed Phase 2 ATOMIC-AHF study.

ArQule (NASDAQ: ARQL) plummeted 15.05% to $2.37. ArQule's PEG ratio is -1.16.

Suntech Power Holdings Co (NYSE: STP) dropped 14.55% to $0.88 after the company provided an update on restructuring process.

IFM Investments (NYSE: CTC) dropped 11.60% to $2.25. IFM Investments' trailing-twelve-month ROE is -6.33%.

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets


Related Articles (ARQL + CTC)

View Comments and Join the Discussion!